Neuroone Medical Technologies (NMTC) Operating Leases (2019 - 2026)

Neuroone Medical Technologies (NMTC) has reported Operating Leases for 8 consecutive years, with $73320.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 58.19% year-over-year to $73320.0; the trailing twelve-month figure through Jun 2026 stood at $73320.0 (down 58.19% YoY), and the FY2025 full-year result was $143148.0, down 26.36% from the prior year.
• Operating Leases fell to $73320.0 in Q2 2026 per NMTC's latest filing, from $92361.0 in the prior quarter.
• Across five years, Operating Leases topped out at $272405.0 in Q4 2022 and bottomed at $20982.0 in Q4 2023.
• Historically, Operating Leases has averaged $180883.7 across 5 years, with a median of $202895.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Operating Leases sank 92.3% in 2023, then jumped 1031.34% in 2024.
• Over 5 years, Operating Leases stood at $272405.0 in 2022, then tumbled by 92.3% to $20982.0 in 2023, then surged by 1031.34% to $237377.0 in 2024, then sank by 53.5% to $110374.0 in 2025, then slumped by 33.57% to $73320.0 in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $73320.0, $92361.0, and $110374.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.